Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Zacks Upgrade CXR To A BUY
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Comment by wordlesson Jul 15, 2016 9:56am
173 Views
Post# 25055449

RE:RE:RE:Zacks Upgrade CXR To A BUY

RE:RE:RE:Zacks Upgrade CXR To A BUYIf I thought $US23 was all this stock would do, I wouldn't be wasting my time here. Wouldn't surprise me to see this clos to $US30 after earnings are released in a month.


wallop13 wrote: A 10% upside is conservative indeed. But I'll take the upgrade over VRX being named the bear of the day today with a strong sell rating. So it could be worse ;)

VeggieHater wrote:

I saw this yesterday as well, but didn't post because Zacks also quotes a year target of $23.00 for stock.  Insulting.

 




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities